42 CFR 427.504
§ 427.504 Manufacturer access to Rebate Reports.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 427.504, § 427.504 Manufacturer access to Rebate Reports, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/205486
- Permanent ID
ys:prov:205486@1- SHA-256
e2856c8c7e6b9bb749c1f9c495d4cb558f70cf6179da783adea59d87fe57a5ad
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) General. CMS will establish a method and process for a manufacturer of the Part B rebatable drug to:
(1) Access the manufacturer's Rebate Report as set forth in §§ 427.501 and 427.502, including any report of reconciled rebate amount as set forth in §§ 427.501(d) and 427.502(c)(2)(ii);
(2) Submit a Suggestion of Error as set forth in §§ 427.502(c)(1)(ii) and (c)(2)(i) and 427.503; and
(3) Pay a rebate amount as set forth in § 427.505.
(b) [Reserved]
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.